This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Charlotte's Web Holdings, Inc.’s CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences are collaborating to advance hemp cannabinoid science through a research program that provides a better understanding of the therapeutic uses and safety of cannabinoids.
While 2020 posed more than its fair share of challenges, the cannabis industry has fared reasonably well. Most US states designated cannabis as an essential business during the COVID-19 pandemic, and sales have continued to gain ground as increasingly diverse cannabis consumer demographics evolve and mature.?
Matthew Anderson, CEO of Vanguard Scientific, offered insights on the challenges cannabis ingredient suppliers and buyers face from seed to sale during Cannabis Products Exchange, held virtually July 30-31.
Willow Biosciences Inc. says it has successfully developed a scalable process for producing cannabigerol (CBG) with greater than 99 percent purity, no detectable THC and demonstrated production at 500-litre scale.
Demetrix Inc., a biotechnology company that makes safe and effective cannabinoids, has commenced 15,000-liter demo-scale fermentation production of the rare cannabinoid cannabigerol (CBG).
Research is underway to help determine the potential of cannabis in the realm of pain management. This is particularly important work in light of the ongoing opioid crisis in America.